Dramatic development of brain connectome takes place during the 3rd trimester, mediated by transcriptome. Transcriptome is complete set of gene-expressed mRNAs and is heterogeneous across brain regions and dynamic throughout development. The transcriptomic basis of structural connectome in this critical developmental stage is unknown. In this study, we identified transcription genes most significantly correlated to nodal efficiency and degree centrality of macroscale structural connectome based on diffusion MRI of 77 preterm brains and over 60,000 quantified transcriptomes. These identified transcription genes such as MYRF regulating oligodendrocyte differentiation and myelination may shed light into the transcriptomic basis of structural connectome development.
[1] Ouyang, M., Dubois, J., Yu, Q., Mukherjee, P., & Huang, H. (2019). Delineation of early brain development from fetuses to infants with diffusion MRI and beyond. Neuroimage, 185, 836-850.
[2] Huang, H., Jeon, T., Sedmak, G., Pletikos, M., Vasung, L., Xu, X., ... & Mori, S. (2012). Coupling diffusion imaging with histological and gene expression analysis to examine the dynamics of cortical areas across the fetal period of human brain development. Cerebral cortex, 23(11), 2620-2631.
[3] Fornito, A., Arnatkevičiūtė, A., & Fulcher, B. D. (2018). Bridging the gap between connectome and transcriptome. Trends in cognitive sciences.
[4] Reardon, P. K., Seidlitz, J., Vandekar, S., Liu, S., Patel, R., Park, M. T. M., ... & Raznahan, A. (2018). Normative brain size variation and brain shape diversity in humans. Science, 360(6394), 1222-1227.
[5] Whitaker, K. J., Vértes, P. E., Romero-Garcia, R., Váša, F., Moutoussis, M., Prabhu, G., ... & Bullmore, E. (2016). Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome. Proceedings of the National Academy of Sciences, 113(32), 9105-9110.
[6] Hawrylycz, M. J., Lein, E. S., Guillozet-Bongaarts, A. L., Shen, E. H., Ng, L., Miller, J. A., ... & Jones, A. (2012). An anatomically comprehensive atlas of the adult human brain transcriptome. Nature, 489(7416), 391.
[7] Li, M., Santpere, G., Kawasawa, Y. I., Evgrafov, O. V., Gulden, F. O., Pochareddy, S., ... & Sestan, N. (2018). Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science, 362(6420), eaat7615.
[8] Engle, W. A. (2004). Age terminology during the perinatal period. Pediatrics, 114(5), 1362-1364.
[9] Rubinov, M., & Sporns, O. (2010). Complex network measures of brain connectivity: uses and interpretations. Neuroimage, 52(3), 1059-1069.
[10] Achard, S., & Bullmore, E. (2007). Efficiency and cost of economical brain functional networks. PLoS computational biology, 3(2), e17.
[11] Van Den Heuvel, M. P., & Sporns, O. (2011). Rich-club organization of the human connectome. Journal of Neuroscience, 31(44), 15775-15786.
[12] Hornig, J., Fröb, F., Vogl, M. R., Hermans-Borgmeyer, I., Tamm, E. R., & Wegner, M. (2013). The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating oligodendrocytes. PLoS genetics, 9(10), e1003907.
[13] Bujalka, H., Koenning, M., Jackson, S., Perreau, V. M., Pope, B., Hay, C. M., ... & Srinivasan, R. (2013). MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS biology, 11(8), e1001625.
[14] Olmos-Serrano, J. L., Kang, H. J., Tyler, W. A., Silbereis, J. C., Cheng, F., Zhu, Y., ... & Sestan, N. (2016). Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron, 89(6), 1208-1222.
[15] Silbereis, J. C., Pochareddy, S., Zhu, Y., Li, M., & Sestan, N. (2016). The cellular and molecular landscapes of the developing human central nervous system. Neuron, 89(2), 248-268.
[16] Volpe, J. J. (2008). Neurology of the Newborn. Elsevier Health Sciences.
[17] Cai, L., Huang, T., Su, J., Zhang, X., Chen, W., Zhang, F., ... & Chou, K. C. (2018). Implications of newly identified brain eQTL genes and their interactors in Schizophrenia. Molecular Therapy-Nucleic Acids, 12, 433-442.